Therapeutic Areas/Disease States: 

Hemophilia 

Budget: $100,000 - $125,000

Intended Audience: 

• Physicians (Hematologists / Hemophilia Specialists)
• Nurses
• Other Hemophilia Treatment Center Team Members
• Patients / Caregivers
• Managed Care

Bayer Hematology Rationale for Educational Support: 

Areas of interest based on referenced literature:

• Managing Mild to Moderate Hemophilia A: Addressing Treatment Challenges and the Importance of Early Factor VIII Prophylaxis in Patient Care to Preserve Joint Health

Accredited Proposal Requirements: 

The proposal must be compliant with standards and guidelines for commercial support (e.g., ACCME). 
All supporting documents should be in PDF format and the proposal should include:

• Needs assessment
• Educational design and rationale for selection
• Learning Objectives
• Proposed Faculty
• Participant Recruitment Plan
• Outcomes Strategy/plan
• Definition of Successful Program
• Detailed Budget

Provider Justification: 

1. Copy of most recent accreditation letter and status
2. Samples of other programs in similar therapeutic areas

Process 

Applications/proposals which are submitted and determined to be complete are reviewed monthly

Acceptance of a Bayer educational grant indicates that you will:

• Reconcile grant funding within 60 days of completion of the educational program
• Permit a Bayer Medical Affairs representative to audit live programs of at least $5000 (Bayer Compliance staff may also audit live programs and/or review the use of the grant)
• Share activity data and outcomes metrics within 30 days of their availability

Literature/Data Referenced 

1. Mancuso, et al. J Thromb Haemost 2018; 16: 2106–10
2. Boeriu, et al. J. Clin. Med. 2022, 11, 3322
3. Walsh, et al. Haemophilia. 2021;27(Suppl. 1):25–32
4. Den Uijl, et al. Hemophilia 2009; 15, 83-90
5. Kloosterman, et al. Blood Adv 2022; 6 (14): 4256–4265
6. Zwagemaker, et al. J Thromb Haemost. 2022; 20:1126–1137
7. Maseide, et al. Haemophilia. 2020; 26:891–897
8. Di Minno, et al. Semin Thromb Hemost 2013; 39: 723–731
9. Castaman, et al. Journal of Clinical Medicine 2023; 12, 1368.
10. Srivastava et al. Haemophilia 2020(26):1-158